Stegemann, Agatha <br/><br/>
The α7 Nicotinic Acetylcholine Receptor: A Promising Target for the Treatment of Fibrotic Skin Disorders.  [electronic resource] 

 -  The Journal of investigative dermatology  12 2020 
 - 2371-2379 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1016/j.jid.2020.04.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Bleomycin--toxicity<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cells, Cultured<br/>Collagen--metabolism<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Fibroblasts--drug effects<br/>Fibrosis<br/>Genetic Vectors--administration & dosage<br/>Humans<br/>Male<br/>Mice<br/>Primary Cell Culture<br/>Quinuclidines--pharmacology<br/>Receptor, Transforming Growth Factor-beta Type I--genetics<br/>Scleroderma, Systemic--chemically induced<br/>Skin--cytology<br/>alpha7 Nicotinic Acetylcholine Receptor--agonists